Curative Biotechnology Inc (CUBT)

[conix]

Push that price down...to take a position.

There is little incentive to participate in discourse unless there is an agenda. Holders have understandable agendas. Those who do not hold have unknown agendas. And they are probably not altruistic in nature.

For what CUBT has---$23 Million in market cap is very low. Having the NIH fund the clinical trials alone is worthy of a higher valuation. A Patent in their IP portfolio is worth $$$.

A Priority Review Voucher (PRV) opportunity is worth more.

Multiple promising treatments with their biggest hurdle is capital to advance on all fronts.

But only $23 Million market cap?

There are other stocks out there that you could own and encourage others to join you. Why stay here?